🔗 Permalink

Inventor profile of:

Michael Detmar

City:

Boppelsen

Country:

Switzerland

Published Applications:

Last publication date:

2022-08-18

Top Assignees for applications by Michael Detmar

The entities that hold a legal rights for patent applications filed by inventor Detmar Michael:

ETH ZURICH 5 Zurich, Switzerland
The General Hospital Corporation 4 Boston, MA United States
SHISEIDO COMPANY, LTD. 3 Tokyo, Japan
UNIVERSITAET BASEL 3 Basel, Switzerland
UNIVERSITAT BASEL 2 Basel, Switzerland
ETH ZUERICH 2 Zuerich, Switzerland
Eth Zuerich 1 Zurich, Switzerland
DICRONIS SAGL 1 Monteggio, Switzerland

Recent patent applications by Detmar Michael

Michael Detmar from Boppelsen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-08-18

US20220257501A1

Human necessities

Cosmetic Preparations Comprising Natural Activators

#2 | 2022-06-09

US20220175696A1

Human necessities

Promotion of lymphatic function

#3 | 2022-02-24

US20220054396A1

Human necessities

Cosmetic preparations comprising Daphne extracts

#4 | 2020-05-14

US20200147004A1

Human necessities

PROMOTION OF LYMPHATIC FUNCTION

#5 | 2018-07-12

US20180196064A1

Physics

Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator

#6 | 2018-04-26

US20180110882A1

Human necessities

Compositions for circulatory system visualization

#7 | 2016-12-22

US20160367499A1

Human necessities

PROMOTION OF LYMPHATIC FUNCTION

#8 | 2015-10-22

US20150301064A1

Physics

Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator

#9 | 2015-01-29

US20150030611A1

Chemistry; metallurgy

Monitoring and Modulating HGF/HGFR Activity

#10 | 2013-10-24

US20130280311A1

Human necessities

Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage

#11 | 2013-03-14

US20130064833A1

Chemistry; metallurgy

Monitoring and modulating HGF/HGFR activity

#12 | 2010-09-09

US20100227821A1

Chemistry; metallurgy

MONITORING AND MODULATING HGF/HGFR ACTIVITY

#13 | 2008-07-24

US20080176851A1

Human necessities

Method for inhibiting lymphangiogenesis and inflammation

#14 | 2007-09-27

US20070224137A1

Human necessities

Methods of reducing skin damage and edema

#15 | 2007-01-11

US20070010443A1

Chemistry; metallurgy

Monitoring and modulating HGF/HGFR activity

#16 | 2005-12-22

US20050281761A1

Human necessities

Methods of preventing UVB-induced skin damage

#17 | 2005-11-10

US20050250799A1

Human necessities

Protease inhibitors for treatment of wrinkles

InventorID:

138668 ⎘